Market Research Reports

Needle-Free Drug Delivery Devices Market (Jet Injectors, Inhalers, Transdermal Patch and Novel Needle Technology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

75pages
Published Date: 2014-05-21
 

Description



Needle-free drug delivery devices are novel techniques to introduce drugs into patient’s body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. Needle-Free Drug Delivery market report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications. Needle-free  drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The market for these technologies has been extensively analyzed on the basis of factors such as technology, durability, value, user preference, regulatory norms and others. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these applications has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for the development of home-care and self medication devices and others. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Geographically, the needle-free drug delivery devices market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market for these geographies has been extensively analyzed on the basis of factors such as regulatory environment, usage pattern, product penetration and others. The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the needle-free drug delivery devices market report comprises a qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis.

The needle-free drug delivery devices market report also provides a highlight of the competitive landscape of the market, wherein the market share analysis of the leading players in the needle-free drug delivery devices market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the needle-free drug delivery devices market such as Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, 3M, Pharmajet, and Zogenix, Inc. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global needle-free drug delivery devices market is segmented as follows:
  • Needle-Free Drug Delivery Devices Market, by Technology
    • Jet Injectors
    • Competing Needle-free Technologies
      • Novel needle-free technology
      • Inhaler technology
      • Transdermal patch technology
  • Needle-Free Drug Delivery Devices Market, by Applications
    • Vaccine Delivery: Developing Immune Response
    • Pain Management
    • Insulin Delivery for Diabetes
    • Paediatric Injections
    • Others
  • Needle-Free Drug Delivery Devices Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

Table of Contents


Table of Contents

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
              1.3.1.1 Secondary Research
              1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Needle-Free Drug Delivery Devices Market (2012 & 2019)
2.2 Global Needle-Free Drug Delivery Devices Market, by Applications, 2012 (USD Million)
2.3 Comparative Analysis: Global Needle-Free Drug Delivery Devices Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
      3.2.1 Drivers
               3.2.1.1 Improving patient compliance and acceptability for novel technologies
               3.2.1.2 Increasing focus on pediatric and geriatric population
               3.2.1.3 Increasing incidences of NCDs to enhance demand
       3.2.2 Restraints
               3.2.2.1 Technical barriers restrict the market growth
       3.2.3 Market Opportunities
               3.2.3.1 Self-administering and home healthcare needle-free drug delivery devices
               3.2.3.2 Expanding therapeutic applications of needle-free drug delivery devices
3.3 Porter’s Five Forces Analysis: Global Needle-free Drug Delivery Devices Market
       3.3.1 Bargaining power of suppliers
       3.3.2 Bargaining power of buyers
       3.3.3 Threat of substitutes
       3.3.4 Threat of new entrants
       3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis

Chapter 4 Needle-Free Drug Delivery Market, by Technology
4.1 Overview
       4.1.1 Global Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
4.2 Jet Injectors
4.3 Competing Needle-Free Technologies
       4.3.1 Global Competing Needle-Free Technologies Market Revenue, 2011 – 2019 (USD Million)
       4.3.2 Novel Needle Technology
       4.3.3 Inhaler Technology
       4.3.4 Transdermal Patch Technology

Chapter 5 Needle-Free Drug Delivery Devices Market, by Applications
5.1 Overview
       5.1.1 Global Needle-Free Drug Delivery Devices Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Vaccine Delivery: Developing Immune Response
5.3 Pain Management
5.4 Insulin Delivery for Diabetes
5.5 Pediatric Injections
5.6 Other Applications

Chapter 6 Needle-Free Drug Delivery Devices Market, by Geography
6.1 Overview
       6.1.1 Global Needle-Free Drug Delivery Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
       6.2.1 North America Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
6.3 Europe
       6.3.1 Europe Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
6.4 Asia Pacific
       6.4.1 Asia-Pacific Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
6.5 Rest of the World
       6.5.1 RoW Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)

Chapter 7 Competitive Landscape
       7.1.1 Market Share Analysis by Key Players, 2012 (Value %)

Chapter 8 Recommendations
8.1 Focus on developing technologically sophisticated needle-free drug delivery devices
8.2 Focus on developing user-friendly and cost-effective needle-free drug delivery devices
8.3 Focus on emerging markets of Asia-Pacific and Latin America

Chapter 9 Company Profiles
9.1 Antares Pharma, Inc.
       9.1.1 Company Overview
       9.1.2 Financial Overview
       9.1.3 Product Portfolio
       9.1.4 Business Strategies
       9.1.5 Recent Developments
9.2 Glide Pharmaceutical Technologies Ltd.
       9.2.1 Company profile
       9.2.2 Financial Overview
       9.2.3 Product Portfolio
       9.2.4 Business Strategies
       9.2.5 Recent Developments
9.3 Injex Pharma AG
       9.3.1 Company Overview
       9.3.2 Financial Overview
       9.3.3 Business Strategies
       9.3.4 Recent Developments
9.4 3M
       9.4.1 Company Overview
       9.4.2 Financial Overview
       9.4.3 Product Portfolio
       9.4.4 Business Strategies
       9.4.5 Recent Developments
9.5 Pharmajet, Inc.
       9.5.1 Company Overview
       9.5.2 Financial Overview
       9.5.3 Product Portfolio
       9.5.4 Business Strategies
9.6 Zogenix, Inc.
       9.6.1 Company Overview
       9.6.2 Financial Overview
       9.6.3 Product Portfolio
       9.6.4 Business Strategies
       9.6.5 Recent Developments

List of Figures

FIG. 1 Needle-Free Drug Delivery Devices Market: Market Segmentation
FIG. 2 Global Needle-Free Drug Delivery Devices Market, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Needle-Free Drug Delivery Devices Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Needle-free Drug Delivery Devices Market
FIG. 5 Market Attractiveness Analysis: Global Needle-Free Drug Delivery Devices Market
FIG. 6 Global Jet Injectors Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Novel Needle Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Inhaler Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Transdermal Patch Technology Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Vaccine Delivery (Developing Immune Response) Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Pain Management Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Insulin Delivery for Diabetes Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Pediatric Injections Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Other Applications Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 North America Needle-free Drug Delivery Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Europe Needle-free Drug Delivery Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Asia-Pacific Needle-free Drug Delivery Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 RoW Needle-free Drug Delivery Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Market Share Analysis: Needle-Free Drug Delivery Devices Market, 2012 (Value %)
FIG. 20 Antares Pharma, Inc.: Annual Revenues, 2010–2012 (USD Million)
FIG. 21 3M Company, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Zogenix, Inc. Annual Revenue: 2011 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Needle-Free Drug Delivery Devices Market (2012 & 2019)
TABLE 2 Global Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 3 Global Competing Needle-Free Technologies Market Revenue, 2011 – 2019 (USD Million)
TABLE 4 Global Needle-Free Drug Delivery Devices Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 5 Global Needle-Free Drug Delivery Devices Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 6 North America Needle-Free Drug Delivery Devices Market Revenue, by Technology,2011 – 2019 (USD Million)
TABLE 7 Europe Needle-Free Drug Delivery Devices Market Revenue, by Technology,2011 – 2019 (USD Million)
TABLE 8 Asia-Pacific Needle-Free Drug Delivery Devices Market Revenue, by Technology,2011 – 2019 (USD Million)
TABLE 9 RoW Needle-Free Drug Delivery Devices Market Revenue, by Technology,2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Needle-free drug delivery devices are novel techniques to induce drugs into patients without invading the skin tissue with a conventional needle. Drug delivery plays integral role in the field of healthcare; according to World Health Organization (WHO) nearly 12 billion injections are administered worldwide annually for medical applications and 5% of it are used for immunization. A needle-free drug delivery system can deliver the drug either actively or passively and is a rational alternative to the traditional drug delivery system i.e. through needle. In the case of needle-free drug delivery device for delivering the drug actively, a driving force is necessary that assists the transport of drug across the skin. Thus, in needle-free drug delivery devices jet injectors, electroporation, iontophoresis, ultrasound, powder injection, and tape stripping act as a driving force for drug delivery. Factors such as high market demand for painless drug delivery, increasing research and development investments and rising home healthcare supports the growth of the global needle-free drug delivery devices market. 

Needle-free drug delivery devices market is segmented on the basis of technology and applications. Technology segment is further segmented into jet injectors and competing needle-free technologies. Competing technologies include novel needle technology, inhaler technology and transdermal patch. In 2012, competing needle-free technologies accounted for the largest market share in the global needle-free drug delivery devices market owing to factors such as ease in usage of devices, compact design, non-invasive treatment, cost-efficient technique and time-saving process. The application market is further classified as vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and others. In case of applications segment insulin delivery for diabetes accounted for the largest share in 2012 due to rising prevalence of diabetic patients who are in need of painless insulin delivery devices. Thus, needle-free insulin delivery devices have high market demand and hence it accounted for the largest share among all the application segments.

Geographically, North America accounted for the largest share of the global needle-free drug delivery devices market. This growth was mainly attributed to rising public awareness against novel drug delivery systems, increasing government initiatives for introduction of needle-free drug delivery devices in community vaccination programs, growing home healthcare and key players domiciled in this region. Asia-Pacific region is expected to grow at the highest CAGR during the forecast period from 2013 to 2019 owing to rising prevalence of diabetes and increasing healthcare awareness in this region. 

Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., 3M, Zogenix and Ypsomed Holding AG are some of the key players having presence in the global needle-free drug delivery devices market. 

needle-free-drug-delivery-devices-market
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research